These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 11197250

  • 1. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
    García-Samaniego J, Rodríguez M, Berenguer J, Rodríguez-Rosado R, Carbó J, Asensi V, Soriano V.
    Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250
    [Abstract] [Full Text] [Related]

  • 2. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
    Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ, North American Liver Cancer in HIV Study Group.
    J Hepatol; 2007 Oct; 47(4):527-37. PubMed ID: 17692986
    [Abstract] [Full Text] [Related]

  • 3. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [Abstract] [Full Text] [Related]

  • 4. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M, Icona Foundation Study Group.
    Clin Infect Dis; 2009 Aug 15; 49(4):612-22. PubMed ID: 19591597
    [Abstract] [Full Text] [Related]

  • 5. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN, Wang JH, Liu SL, Hung CH, Chen CH, Tung HD, Chen TM, Huang WS, Lee CM, Chen CC, Changchien CS.
    Cancer; 2006 Nov 01; 107(9):2212-22. PubMed ID: 17019738
    [Abstract] [Full Text] [Related]

  • 6. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
    Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB.
    Arch Intern Med; 2004 Nov 22; 164(21):2349-54. PubMed ID: 15557414
    [Abstract] [Full Text] [Related]

  • 7. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 22; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M.
    Am J Gastroenterol; 2002 Jan 22; 97(1):156-61. PubMed ID: 11808941
    [Abstract] [Full Text] [Related]

  • 10. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR, Bhan AK, Zheng H, Chung RT.
    Cancer; 2007 Jun 15; 109(12):2490-6. PubMed ID: 17487861
    [Abstract] [Full Text] [Related]

  • 11. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.
    Alcohol Clin Exp Res; 2003 Aug 15; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA, Rendón Unceta P, Tejada Cabrera M, Infante Hernández JM, Correro Aguilar F, Díaz García F, Benítez Rodríguez E, Mangas Rojas A, Martín Herrera L.
    Rev Esp Enferm Dig; 2000 Jul 15; 92(7):458-69. PubMed ID: 11026763
    [Abstract] [Full Text] [Related]

  • 13. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
    Aizawa Y, Shibamoto Y, Takagi I, Zeniya M, Toda G.
    Cancer; 2000 Jul 01; 89(1):53-9. PubMed ID: 10897000
    [Abstract] [Full Text] [Related]

  • 14. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G, Calza L, Manfredi R, Chiodo F.
    Infection; 2004 Feb 01; 32(1):33-46. PubMed ID: 15007741
    [Abstract] [Full Text] [Related]

  • 15. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.
    Hamada H, Yatsuhashi H, Yano K, Daikoku M, Arisawa K, Inoue O, Koga M, Nakata K, Eguchi K, Yano M.
    Cancer; 2002 Jul 15; 95(2):331-9. PubMed ID: 12124834
    [Abstract] [Full Text] [Related]

  • 16. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M.
    J Gastroenterol Hepatol; 2008 Sep 15; 23(9):1431-6. PubMed ID: 18854000
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinoma and hepatitis C in Mexico.
    Mondragón-Sánchez R, Garduño-López AL, Hernández-Castillo E, Gómez-Gómez E, Ruiz-Molina JM.
    Hepatogastroenterology; 2005 Sep 15; 52(64):1159-62. PubMed ID: 16001652
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K, Shigematsu H, Irie K, Ishibashi H.
    Hepatogastroenterology; 2003 Sep 15; 50(54):2022-7. PubMed ID: 14696457
    [Abstract] [Full Text] [Related]

  • 19. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH, Hung CC, Kao JH, Chang SY, Chen MY, Hsieh SM, Chen PJ, Chang SC.
    Clin Infect Dis; 2007 Apr 01; 44(7):988-95. PubMed ID: 17342655
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection.
    Jacobson IM, Davis GL, El-Serag H, Negro F, Trépo C.
    Clin Gastroenterol Hepatol; 2010 Nov 01; 8(11):924-33; quiz e117. PubMed ID: 20713178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.